Oral: Methodology - New Modelling Approaches

Automating Population Pharmacokinetic Model Development using Machine Learning

Thursday 16 October, 2025

Population pharmacokinetic (popPK) models are used in decision-making throughout drug development to inform dose selection, clinical study design, and labelling…

Read more

Meta-analysis of parameter estimates of non-linear mixed effect models using Approximate Bayesian Computation: application to population pharmacokinetics

Thursday 16 October, 2025

Introduction: Non-Linear Mixed Effect Models (NLMEM) are a gold standard tool to analyze pharmacokinetic (PK) data. Generally, numerous population PK…

Read more

Bayesian framework for multi-source data integration – application to Human extrapolation from preclinical studies

Thursday 16 October, 2025

Introduction: In preclinical research, including in vitro studies (conducted within subcellular fractions, cell cultures, micro-organisms, organoid models, etc.), in vivo…

Read more

The estimates for the absorption rate constant in pharmacokinetics and pharmacometrics are wrong: A new era based on the finite absorption time concept rises

Thursday 16 October, 2025

Introduction: Common practice in pharmacokinetic analyses and data evaluation as well as in simulations is based on the assumption that…

Read more

A methodology to de-shrink Empirical Bayes Estimates

Thursday 16 October, 2025

Objectives:  Therapeutic drug monitoring (TDM) is used for some drugs to evaluate drugs exposures and optimize the therapeutic management of…

Read more

Benefits of integrating machine learning with clinical pharmacology principles for predictive pharmacokinetic modeling

Thursday 16 October, 2025

Introduction:  Machine learning (ML) applications in clinical pharmacology have been rapidly increasing over the last several years (1). While most…

Read more

A Semi Parametric Method for the Estimation of End of Treatment Effect

Thursday 16 October, 2025

Objectives: End of treatment effect is a commonly used endpoint in Randomized Clinical Trials (RCTs). Several methods are used for…

Read more

The Neural Mixed Effects algorithm: leveraging machine learning for pharmacokinetic modelling

Thursday 16 October, 2025

Objectives: There is much interest in the application of machine learning (ML) algorithms for the personalisation of treatment. Nonlinear mixed-effects…

Read more

A novel mathematical model of neurofilament trafficking in healthy subjects

Thursday 16 October, 2025

Objectives: Neurofilaments (NFs) are cytoskeletal proteins of the neurons present mainly in the axons. Following axonal injury, NFs are released…

Read more

Development of a multilevel nonlinear joint model to characterize effect of tumor variability under immunotherapy

Thursday 16 October, 2025

Context: Immunotherapy showed impressive results in oncology in the past few years, but novel patterns of response complicate the association…

Read more